Monday, October 26, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
News articleSeeking Alpha· March 29, 2026

Earnings week ahead: NKE, TLRY, SPCE, BYND, NNDM, CAG, and more

View original at seekingalpha.com
Earnings week ahead: NKE, TLRY, SPCE, BYND, NNDM, CAG, and more [Nest of Eggs] LindaJoHeilman As the calendar turns from March to April, a holiday-shortened week still delivers a diverse set of earnings with the potential to offer fresh directional cues…
Opening lines of the source · Seeking Alpha · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Three Mile Island plant cannot hit grid until 2031

    60% confidence
  • Nike faces margin pressure from tariffs of approximately $1.5B annually and inventory actions, but these are temporary with recovery ahead

    60% confidence
  • Tilray upgraded to Hold, noting that while recent results showed revenue growth and narrowing losses, gross margins declined to 26% due to mix pressures. The BrewDog deal is expected to add ~$200M in annual revenue and $6–8M in adjusted EBITDA

    60% confidence
  • Nike has valuation concerns and estimated ~20% downside despite potential relief from lower tariffs, noting continued policy uncertainty

    60% confidence
  • Acuity Brands rated Hold, noting the stock is trading near fair value with ~8% forward return potential

    60% confidence
  • Virgin Galactic Holdings earns a Sell rating due to weakening momentum and profitability relative to industrial peers

    60% confidence
  • Nike maintains Strong Buy rating with $85 price target, implying ~33% upside and 2.6% yield, citing early success of the Win Now turnaround with 43% Q2 EPS beat, 8% wholesale growth, and 20%+ gains in the running category

    60% confidence
  • Nike upgraded from Hold to Buy rating

    60% confidence
  • Acuity Brands rates as Sell citing valuation concerns and negative EPS revisions

    60% confidence
  • Nike has strong liquidity of approximately $8.35B with insider and institutional buying, and renewed partnerships supporting a multi-year recovery

    60% confidence
  • Tilray upgraded to Hold from Strong Sell

    60% confidence
  • Nike's turnaround remains uncertain, warranting a more neutral stance

    60% confidence
  • Nike downgraded to Hold citing declining profitability, elevated multiples, and ongoing weakness in China

    60% confidence

Cited in these Via News reports

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biotech Catalyst Window: ESMO Data, the Ivonescimab PDUFA and Small-Cap Delistings
Mid-October to November 2026 is a dense catalyst period for clinical-stage biotech. Positive late-stage readouts (ALOFT-IPF, TELIGAN, MIUDELLA, the duvakitug extension) and the ESMO 2026 presentations lead up to the FDA's 14 November PDUFA date for the ivonescimab BLA. At the opposite end of the market, Spago Nanomedical is moving to delist from Nasdaq First North, which shows how hard it is for micro-cap developers to fund themselves. Value is concentrating in companies with late-stage data and near-term regulatory outcomes.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,994
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,994 facts checked against source5,500 source documents archived
Query this data → isubstrate.com